GLP-1 agonists like Ozempic, Trulicity, Mounjaro, Victoza, Wegovy started as a way to treat diabetes but have since become popular for weight loss.
Which Big Pharmas would be most impacted by higher tariffs? Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader weigh in. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback